Cargando…

ELISA-Based Assay for Studying Major and Minor Group Rhinovirus–Receptor Interactions

Rhinovirus (RV) infections are a major cause of recurrent common colds and trigger severe exacerbations of chronic respiratory diseases. Major challenges for the development of vaccines for RV include the virus occurring in the form of approximately 160 different serotypes, using different receptors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pazderova, Petra, Waltl, Eva E., Niederberger-Leppin, Verena, Flicker, Sabine, Valenta, Rudolf, Niespodziana, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350259/ https://www.ncbi.nlm.nih.gov/pubmed/32570763 http://dx.doi.org/10.3390/vaccines8020315

Ejemplares similares

Antibody Conjugates Bispecific for Pollen Allergens and ICAM-1 with Potential to Prevent Epithelial Allergen Transmigration and Rhinovirus Infection
por: Weichwald, Christina, et al.
Publicado: (2023)

Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies
por: Niespodziana, Katarzyna, et al.
Publicado: (2022)

Betamethasone prevents human rhinovirus- and cigarette smoke- induced loss of respiratory epithelial barrier function
por: Waltl, Eva E., et al.
Publicado: (2018)

Characterisation and culture of primary human nasal epithelial cells and the influence of Interferon-gamma
por: Waltl, Eva, et al.
Publicado: (2014)

Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory Symptoms
por: Niespodziana, Katarzyna, et al.
Publicado: (2014)

Establishment of a cell culture model based on primary epithelial cells to investigate damage and repair of respiratory epithelial cells
por: Waltl, Eva E, et al.
Publicado: (2015)

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection
por: Cornelius, Carolin, et al.
Publicado: (2016)

Primary Nasal Epithelial Cells From Allergic and Non-allergic Individuals Show Comparable Barrier Function
por: Waltl, Eva E., et al.
Publicado: (2019)

Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection
por: Schögler, Aline, et al.
Publicado: (2016)

Microarray-Based Analyses of Rhinovirus Species-Specific Antibody Responses in Exacerbated Pediatric Asthma in a German Pediatric Cohort
por: Sallard, Erwan, et al.
Publicado: (2022)

Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE
por: Zghaebi, Mohammed, et al.
Publicado: (2021)

Microarray Technology May Reveal the Contribution of Allergen Exposure and Rhinovirus Infections as Possible Triggers for Acute Wheezing Attacks in Preschool Children
por: Niespodziana, Katarzyna, et al.
Publicado: (2021)

RIPK1 Is Cleaved by 3C Protease of Rhinovirus A and B Strains and Minor and Major Groups
por: Croft, Sarah N., et al.
Publicado: (2021)

Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layers
por: Madritsch, Christoph, et al.
Publicado: (2015)

Highly sensitive ELISA‐based assay for quantification of allergen‐specific IgE antibody levels
por: Karsonova, Antonina, et al.
Publicado: (2020)

PreDicta chip-based high resolution diagnosis of rhinovirus-induced wheeze
por: Niespodziana, Katarzyna, et al.
Publicado: (2018)

Major and Minor Group Rhinoviruses Elicit Differential Signaling and Cytokine Responses as a Function of Receptor-Mediated Signal Transduction
por: Schuler, Bryce A., et al.
Publicado: (2014)

An ELISA for the detection of rhinovirus specific antibody in serum and nasal secretion
por: Barclay, W.S., et al.
Publicado: (1987)

Are the Terms Major and Minor Allergens Useful for Precision Allergology?
por: Caraballo, Luis, et al.
Publicado: (2021)

Recombinant allergy vaccines based on allergen-derived B cell epitopes
por: Valenta, Rudolf, et al.
Publicado: (2017)

High density IgE recognition of the major grass pollen allergen, Phl p 1, revealed with single chain IgE antibody fragments obtained by combinatorial cloning
por: Madritsch, Christoph, et al.
Publicado: (2014)

Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Insights into Minor Group Rhinovirus Uncoating: The X-ray Structure of the HRV2 Empty Capsid
por: Garriga, Damià, et al.
Publicado: (2012)

Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy
por: Wollmann, Eva, et al.
Publicado: (2015)

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
por: Valenta, Rudolf, et al.
Publicado: (2016)

Trimolecular complex between major birch pollen allergen, Bet v 1, monoclonal allergen-specific human IgE and recombinant CD23
por: Selb, Regina, et al.
Publicado: (2014)

Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response
por: Borochova, Kristina, et al.
Publicado: (2021)

Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma
por: Naumova, Veronika, et al.
Publicado: (2022)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy
por: Flicker, Sabine, et al.
Publicado: (2013)

Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Tracing IgE-Producing Cells in Allergic Patients
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Effects of Nasal Corticosteroids on Boosts of Systemic Allergen-Specific IgE Production Induced by Nasal Allergen Exposure
por: Egger, Cornelia, et al.
Publicado: (2015)

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
por: Focke-Tejkl, Margarete, et al.
Publicado: (2015)

Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients
por: Moreira, Priscila Ferreira de Sousa, et al.
Publicado: (2015)

Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines
por: Weber, Milena, et al.
Publicado: (2017)

Poor association of allergen‐specific antibody, T‐ and B‐cell responses revealed with recombinant allergens and a CFSE dilution‐based assay
por: Eckl‐Dorna, J., et al.
Publicado: (2015)

Induction of allergen-specific blocking IgG using patch delivered recombinant Bet v 1 in guinea pigs
por: Cabauatan, Clarissa, et al.
Publicado: (2014)

Human Rhinovirus Group C in Hospitalized Children, Singapore
por: Tan, Boon-Huan, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_vijlvjvtc3oesvck9t6ugvp01n